# Cardinal Health vs Edwards Lifesciences: stocks compared

URL: https://funkfolio.com/compare/cah-vs-ew

> Cardinal Health ($64.5B, P/E 36.1) and Edwards Lifesciences ($60.6B, P/E 61.3) compared: size, valuation, margins, debt, cash and price change.

---

## Cardinal Health vs Edwards Lifesciences

Cardinal Health (CAH), health care, and Edwards Lifesciences (EW), health care, side by side on market value, valuation, margins, balance sheet and price change. Higher and lower are marked; neither is called better.

Cardinal Health is worth $64.5B on the stock market and Edwards Lifesciences $60.6B: Cardinal Health is valued at 6% more. Cardinal Health trades at 36.1 times earnings and Edwards Lifesciences at 61.3; operating margins in their latest fiscal years were 1.03% and 20.8%. Over the past year Cardinal Health's share price has moved +37.1% and Edwards Lifesciences's +27.5%.

### Key facts

- **Cardinal Health market value:** $64.5B
- **Edwards Lifesciences market value:** $60.6B
- **Cardinal Health P/E:** 36.1
- **Edwards Lifesciences P/E:** 61.3
- **Cardinal Health revenue:** $254.2B FY to 2026-06-30
- **Edwards Lifesciences revenue:** $6.1B FY to 2025-12-31
- **Superinvestors holding both:** 0

Market values as of 18 Nov 2026, 02:52 UTC.

Cardinal Health vs Edwards Lifesciences: every measure side by side

| Measure | Cardinal Health | Edwards Lifesciences |
| --- | --- | --- |
| Sector | Health Care | Health Care |
| Country | United States | United States |
| Fiscal year ends | 2026-06-30 | 2025-12-31 |
| Size |  |  |
| Market cap | $64.5B higher | $60.6B lower |
| Revenue | $254.2B higher | $6.1B lower |
| Earnings | $1.7B higher | $1.1B lower |
| Employees | 58,788 higher | 16,000 lower |
| Total assets | $57.3B higher | $13.7B lower |
| Valuation |  |  |
| P/E | 36.1 lower | 61.3 higher |
| P/S | 0.3 lower | 10.0 higher |
| P/B | — | 5.6 |
| Dividend yield | 0.72% higher | 0.00% lower |
| Profitability |  |  |
| Operating margin | 1.03% lower | 20.8% higher |
| Balance sheet |  |  |
| Net assets | -$2.9B lower | $10.3B higher |
| Total liabilities | $60B higher | $3.4B lower |
| Total debt | $8.9B higher | $598.3M lower |
| Cash on hand | $4.9B higher | $2.9B lower |
| Price change |  |  |
| Today | -1.62% lower | -1.57% higher |
| 1 year | +37.1% higher | +27.5% lower |

Market value, P/E, P/B, dividend yield and price changes are from live quotes (Yahoo Finance; prices may be delayed 15 minutes or more). Revenue, earnings, operating margin and the balance-sheet figures are from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day. P/S sets today's market value against the latest fiscal year's revenue. “Higher” and “lower” compare the two numbers only; a higher P/E or more debt is not better. Dividend yield and P/B are shown only for companies based in the US. A dash means no figure is on file.

### Share price over one year

Each company's share price rebased to 100 on Nov 17, 2025, so the two lines start together. Price only: dividends are not included. Last: Cardinal Health 135.4, Edwards Lifesciences 124.4.

- Cardinal Health (CAH)
- Edwards Lifesciences (EW)

Cardinal Health and Edwards Lifesciences share prices over one year, rebased to 100: Cardinal Health ends at 135.4, Edwards Lifesciences at 124.4.

**The chart as a table**

Month-end share prices rebased to 100

| Month end | CAH | EW |
| --- | --- | --- |
| Nov 28, 2025 | 102.9 | 102.3 |
| Dec 31, 2025 | 99.7 | 100.6 |
| Jan 30, 2026 | 104.2 | 96.0 |
| Feb 27, 2026 | 111.2 | 102.0 |
| Mar 31, 2026 | 102.5 | 94.5 |
| Apr 30, 2026 | 93.5 | 98.5 |
| May 29, 2026 | 95.5 | 102.0 |
| Jun 30, 2026 | 115.2 | 106.8 |
| Jul 31, 2026 | 111.6 | 101.6 |
| Aug 31, 2026 | 113.8 | 107.1 |
| Sep 30, 2026 | 107.9 | 101.9 |
| Oct 30, 2026 | 121.5 | 108.6 |
| Nov 17, 2026 | 135.4 | 124.4 |

### Which superinvestors hold them

From each tracked investor's latest 13F filing. A 13F lists long positions in US-listed shares at a quarter end, filed up to 45 days later.

#### Both (0)

None of the tracked investors.

#### Cardinal Health only (6)

- [Charles Brandes (founder)](https://funkfolio.com/gurus/charles-brandes) 0.4%
- [Jim Simons (1938–2024)](https://funkfolio.com/gurus/jim-simons) 0.3%
- [Joel Greenblatt](https://funkfolio.com/gurus/joel-greenblatt) 0.1%
- [Ray Dalio (founder)](https://funkfolio.com/gurus/bridgewater) 0.1%
- [Mason Hawkins](https://funkfolio.com/gurus/mason-hawkins) 0.1%
- [Larry Robbins](https://funkfolio.com/gurus/larry-robbins) 0.1%

#### Edwards Lifesciences only (9)

- [David Rolfe](https://funkfolio.com/gurus/david-rolfe) 3.1%
- [Howard Gleicher](https://funkfolio.com/gurus/howard-gleicher) 1.6%
- [Brandon Haley](https://funkfolio.com/gurus/brandon-haley) 0.7%
- [Steve Cohen](https://funkfolio.com/gurus/steve-cohen) 0.2%
- [Israel Englander](https://funkfolio.com/gurus/israel-englander) 0.2%
- [Ken Griffin](https://funkfolio.com/gurus/ken-griffin) 0.2%
- [Primecap team](https://funkfolio.com/gurus/primecap) 0.2%
- [Baillie Gifford team](https://funkfolio.com/gurus/baillie-gifford) 0.1%
- [Ron Baron](https://funkfolio.com/gurus/ron-baron) 0.1%

Percentages are each holding's share of that investor's reported portfolio. [Who owns CAH](https://funkfolio.com/stock/CAH/superinvestors) · [Who owns EW](https://funkfolio.com/stock/EW/superinvestors)

### More on Cardinal Health

- [Cardinal Health (CAH) stock page](https://funkfolio.com/stock/CAH)
- [Cardinal Health market cap](https://funkfolio.com/stock/CAH/market-cap)
- [Cardinal Health revenue](https://funkfolio.com/stock/CAH/revenue)
- [Cardinal Health P/E ratio](https://funkfolio.com/stock/CAH/pe-ratio)
- [Cardinal Health operating margin](https://funkfolio.com/stock/CAH/operating-margin)
- [Cardinal Health total debt](https://funkfolio.com/stock/CAH/total-debt)
- [Largest health care companies](https://funkfolio.com/companies/sector/health-care)

### More on Edwards Lifesciences

- [Edwards Lifesciences (EW) stock page](https://funkfolio.com/stock/EW)
- [Edwards Lifesciences market cap](https://funkfolio.com/stock/EW/market-cap)
- [Edwards Lifesciences revenue](https://funkfolio.com/stock/EW/revenue)
- [Edwards Lifesciences P/E ratio](https://funkfolio.com/stock/EW/pe-ratio)
- [Edwards Lifesciences operating margin](https://funkfolio.com/stock/EW/operating-margin)
- [Edwards Lifesciences total debt](https://funkfolio.com/stock/EW/total-debt)
- [Largest health care companies](https://funkfolio.com/companies/sector/health-care)

### Further comparisons

#### Cardinal Health against its closest peers

- [Cardinal Health vs Boston Scientific](https://funkfolio.com/compare/bsx-vs-cah)
- [Cardinal Health vs argenx](https://funkfolio.com/compare/argx-vs-cah)
- [Cardinal Health vs Becton, Dickinson](https://funkfolio.com/compare/bdx-vs-cah)

#### Edwards Lifesciences against its closest peers

- [Edwards Lifesciences vs argenx](https://funkfolio.com/compare/argx-vs-ew)
- [Edwards Lifesciences vs Becton, Dickinson](https://funkfolio.com/compare/bdx-vs-ew)
- [Edwards Lifesciences vs Boston Scientific](https://funkfolio.com/compare/bsx-vs-ew)

### Learn

- [What market capitalization is and is not](https://funkfolio.com/learn/markets/market-capitalization)
- [P/E ratio explained](https://funkfolio.com/learn/stocks/pe-ratio)
- [Market cap vs enterprise value](https://funkfolio.com/learn/markets/market-cap-vs-enterprise-value)

### Questions and answers

**Which is bigger, Cardinal Health or Edwards Lifesciences?**

By market value, Cardinal Health is the larger: $64.5B against $60.6B for Edwards Lifesciences. By revenue in its latest fiscal year, Cardinal Health is the larger: $254.2B against $6.1B for Edwards Lifesciences.

**Which has the higher P/E ratio?**

Edwards Lifesciences: 61.3, against 36.1 for Cardinal Health. A higher P/E means the market pays more for each dollar of the last twelve months' earnings; on its own it does not say which is the better value.

**Which has the higher operating margin?**

Edwards Lifesciences: 20.8%, against 1.03% for Cardinal Health. Operating margin is operating income as a share of revenue in the latest fiscal year.

**Which has the higher dividend yield?**

Cardinal Health: 0.72%, against 0.00% for Edwards Lifesciences. Dividend yield is the last twelve months' dividends as a share of today's share price.

**Which has more debt?**

Cardinal Health: $8.9B, against $598.3M for Edwards Lifesciences. Total debt is borrowings at the end of the latest fiscal year, as each company reported it; it is not set against cash here.

**Which superinvestors own both Cardinal Health and Edwards Lifesciences?**

None of the tracked superinvestors holds both in their latest 13F filing. 6 hold Cardinal Health and 9 hold Edwards Lifesciences.

### Cite this page

Funkfolio, “Cardinal Health vs Edwards Lifesciences”, data as of 18 November 2026. https://funkfolio.com/compare/cah-vs-ew

Underlying data: Yahoo Finance quotes; SEC annual reports collected 2026-11-12; 13F filings.
